EUVIMEDEUVIMED entdecken
Crossref

Highly Synergistic Eradication of 143B Osteosarcoma Cells In Vitro by the Combination of Recombinant Methioninase, Chloroquine, and Rapamycin Targeting Methionine Addiction, Autophagy, and mTOR, Respectively

Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Hiroyuki Tsuchiya und 2 weitere

Anticancer Research · 2025

DOI: 10.21873/anticanres.17481 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Sei Morinaga und 13 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Carbon-Sulfur Lyases, Chloroquine, Osteosarcoma, Autophagy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon-Sulfur LyasesChloroquineOsteosarcomaAutophagySirolimusTOR Serine-Threonine KinasesMethionineBone NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsHumansCell Line, TumorDrug SynergismRecombinant ProteinsCell SurvivalCell Proliferation

Stichwörter der Autor:innen

Hoffman effectRecombinant methioninasechloroquinemethionine addictionosteosarcomarapamycinsynergy

Substanzen

Carbon-Sulfur LyasesL-methionine gamma-lyaseChloroquineSirolimusTOR Serine-Threonine KinasesMethionineRecombinant ProteinsMTOR protein, human

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Morinaga, S., Han, Q., Mizuta, K., Kang, B. M., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2025). Highly Synergistic Eradication of 143B Osteosarcoma Cells In Vitro by the Combination of Recombinant Methioninase, Chloroquine, and Rapamycin Targeting Methionine Addiction, Autophagy, and mTOR, Respectively. Anticancer Research. https://doi.org/10.21873/anticanres.17481

Vancouver

Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, et al. Highly Synergistic Eradication of 143B Osteosarcoma Cells In Vitro by the Combination of Recombinant Methioninase, Chloroquine, and Rapamycin Targeting Methionine Addiction, Autophagy, and mTOR, Respectively. Anticancer Research. 2025. doi:10.21873/anticanres.17481

BibTeX
@article{Morinaga2025,
  author = {Morinaga, Sei and Han, Qinghong and Mizuta, Kohei and Kang, Byung Mo and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Highly Synergistic Eradication of 143B Osteosarcoma Cells In Vitro by the Combination of Recombinant Methioninase, Chloroquine, and Rapamycin Targeting Methionine Addiction, Autophagy, and mTOR, Respectively},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17481}
}
Kostenlos starten →